Connor, Clark & Lunn Investment Management Ltd. Soma Logic, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$22 Billion
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.99 - $2.45 $300,692 - $370,199	-151,102 Reduced 82.34%	32,418 $77,000
Q2 2023 Aug 10, 2023	SELL	$2.1 - $3.36 $269,100 - $430,560	-128,143 Reduced 41.12%	183,520 $423,000
Q1 2023 May 09, 2023	BUY	$2.13 - $3.6 $41,975 - $70,945	19,707 Added 6.75%	311,663 $794,000
Q4 2022 Feb 10, 2023	BUY	$2.05 - $3.47 $598,509 - $1.01 Million	291,956 New	291,956 $732,000

Others Institutions Holding SLGC

# of Institutions

Shares Held

7.48M

Call Options Held

Put Options Held

View Full List

About SomaLogic, Inc.

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

More about SLGC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account